Bone Marrow TransplantationTransplantation, HomologousBone MarrowGraft vs Host DiseaseBone Marrow CellsWhole-Body IrradiationLeukemiaAnemia, AplasticTransplantation ConditioningTissue DonorsTransplantation ChimeraTransplantation, AutologousBone and BonesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveGraft SurvivalCytomegalovirus InfectionsHematopoietic Stem Cell TransplantationHematologic NeoplasmsLeukemia, Myeloid, AcuteLymphocyte DepletionRecurrenceHistocompatibility TestingImmunosuppressive AgentsBusulfanHematopoietic Stem CellsPrecursor Cell Lymphoblastic Leukemia-LymphomaHistocompatibilityLymphocyte TransfusionNuclear FamilyTime FactorsAcute DiseaseRemission InductionRadiation ChimeraBone Marrow PurgingCombined Modality TherapyCyclosporineTransplantation, IsogeneicTreatment OutcomeCyclophosphamideMice, Inbred C57BLT-LymphocytesGraft vs Host ReactionHematopoiesisLeukocyte TransfusionImmunosuppressionBone Marrow DiseasesGraft RejectionSurvival AnalysisRetrospective StudiesCytomegalovirusGraft vs Tumor EffectHepatic Veno-Occlusive DiseaseLeukemia, MyeloidBone Marrow ExaminationBone RemodelingKidney TransplantationChimeraMyelodysplastic SyndromesBone Marrow NeoplasmsHLA AntigensLiver TransplantationHematologic DiseasesGraft vs Leukemia EffectTransplantation ImmunologyStem Cell TransplantationStem CellsLymphoma, Non-HodgkinFatal OutcomeColony-Forming Units AssayImmunocompromised HostMice, Inbred BALB COpportunistic InfectionsActuarial AnalysisSevere Combined ImmunodeficiencyBone DensitySpleenSurvival RateCell DifferentiationLeukocyte CountFollow-Up StudiesFlow CytometryAntineoplastic Combined Chemotherapy ProtocolsDisease-Free SurvivalGranulocyte Colony-Stimulating FactorPneumonia, ViralBone ResorptionGanciclovirCells, CulturedHeart TransplantationAntilymphocyte SerumPancytopeniaMultiple MyelomaInfectionAntigens, CD34CytarabineBlood Group IncompatibilityPolymerase Chain ReactionLymphomaMethotrexateLeukemia, Myelomonocytic, Acute